Close
Help




JOURNAL

Biomarkers in Cancer

Associations of the A66G Methionine Synthase Reductase Polymorphism in Colorectal Cancer: A Systematic Review and Meta-Analysis

Submit a Paper


Biomarkers in Cancer 2015:Suppl. 1 21-28

Review

Published on 29 Oct 2015

DOI: 10.4137/BIC.S25251


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Biomarkers in Cancer

Abstract

Inconsistency in the reported associations between the A66G polymorphism in the methionine synthase reductase (MTRR) gene and colorectal cancer (CRC) prompted a meta-analysis, so that we could obtain a more precise estimate. Databases searches of the published literature yielded 20 case–control studies from 17 articles (8,371 cases and 12,574 controls). We calculated pooled odds ratios (ORs) and 95% confidence intervals in three genetic comparisons (A allele, G allele, and A/G genotype). We found no evidence of overall associations between MTRR A66G and CRC risk (OR 0.96–1.05, P = 0.12–0.44). This was materially unchanged when reanalyzed without the Hardy–Weinberg equilibrium (HWE)-deviating studies (OR 0.97–1.06, P = 0.11–0.65). In the A allele comparison, however, outlier treatment generated significant protection (OR 0.91, P = 0.01). Combined removal of the outliers and HWE-deviating studies reflected this summary effect (OR 0.90, P = 0.01) as did the pooled OR from high-quality studies (OR 0.90, P = 0.01). Only the Asian subgroup showed significant (both at P = 0.05) A allele (OR 1.13) and A/G genotype (OR 0.88) associations. In conclusion, post-outlier A allele effects were protective. Our study also suggests ethnic-specific associations with Asian susceptibility and protection in the A allele and A/G genotype comparisons, respectively. Folate status showed no association of this polymorphism with CRC.



Downloads

PDF  (2.39 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

Supplementary Files 1   (99.69 KB DOCX FORMAT)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Biomarkers in Cancer
I had a great experience in publishing a review article in Biomarkers in Cancer.  The submission process was extremely smooth and peer review was fast and channelized.  At each and every step I was able to monitor the progress.  Response to my communication was instant and every time confirmation emails were sent.  The publication processing team provided excellent support for proof reading and corrections.  I recommend publishing in it and wish them success. ...
Dr Ranjit Chauhan (University of Winnipeg, Winnipeg, MB, Canada)
More Testimonials

Quick Links


New article and journal news notification services